A randomised controlled trial for the evaluation of risk for type 2 diabetes in hypertensive patients receiving thiazide diuretics: Diuretics In the Management of Essential hypertension (DIME) study

BMJ Open

Volumn 4, Issue 7, 2014, Pages

  Ueda, Shinichiro ^a   Morimoto, Takeshi ^b   Ando, Shin Ichi ^c,d   Takishita, Shu Ichi ^a   Kawano, Yuhei ^e   Shimamoto, Kazuaki ^f   Ogihara, Toshio ^g   Saruta, Takao ^h  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c Saiseikai Futsukaichi Hospital   (Japan)

^d KYUSHU UNIVERSITY HOSPITAL   (Japan)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^f SAPPORO MEDICAL UNIVERSITY   (Japan)

^g OSAKA UNIVERSITY   (Japan)

^h KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; GLUCOSE METABOLISM; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOKALEMIA; INTENTION TO TREAT ANALYSIS; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; SAMPLE SIZE; STUDENT T TEST; SYSTOLIC BLOOD PRESSURE; TEACHING HOSPITAL; BLOOD; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; JAPAN; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; TIME FACTOR;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SINGLE-BLIND METHOD; SODIUM CHLORIDE SYMPORTER INHIBITORS; TIME FACTORS;

EID: 84904463854     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004576     Document Type: Article

References (26)

1. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta analysis. JAMA 1997;277:739-45. (Pubitemid 27106227)
2. Medical Research Council Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992;304:405-12.
3. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
4. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J (Clin Res Ed) 1985;291:97-104.
5. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
6. Grossman E, Verdecchia P, Shamiss A, et al. Diuretic treatment of hypertension. Diabetes Care 2011;34(Suppl 2):S313-19.
7. Sarafidis P, Bakris GL. Antihypertensive therapy and the risk of new-onset diabetes. Diabetes Care 2006;29:1167-9. (Pubitemid 44115265)
8. Taylor EN, Hu FB, Curhan GC. Antihypertensive medications and the risk of incident type 2 diabetes. Diabetes Care 2006;29:1065-70. (Pubitemid 44115245)
9. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007;369:201-7. (Pubitemid 46111014)
10. Pocock SJ. Clinical trials: a practical approach. John Wiley, 1983.
11. Treasure T, MacRae KD. Minimisation: the platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does. BMJ 1998;317:362-3.
12. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999 (WHO/NCD/NCS/99.2).
13. http://www.jds.or.jp/modules/study/index.php?content-id=10#english
14. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
15. Thorvaldsen P, Kuulasmaa K, Rajakangas AM, et al. Stroke trends in the WHO MONICA project. Stroke 1997;28:500-6. (Pubitemid 27118368)
16. Luepker RV, Apple FS, Christenson RH, et al. AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute: Case Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies. a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003;108:2543-9.
17. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
18. Fontaine R, Kim M, Kieny R. Die chirurgische Behandlung der peripheren Durch-bluntungsstorungen. Helv Chir Acta 1954;5/6:499-533.
19. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996;276:1886-92. (Pubitemid 26419185)
20. Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium channel blocker or diuretic in the International Nifedipine GITS study: intervention as a goal in hypertension treatment (INSIGHT). Lancet 2000;356:366-72. (Pubitemid 30487492)
21. Bakris G, Molitch M, Hewkin A, et al. Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome. Diabetes Care 2006;29:2592-7. (Pubitemid 44912184)
22. Carlsen JE, Køber L, Torp-Pedersen C, et al. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 1990;300:975-8. (Pubitemid 20144223)
23. Dahlöf B, Devereux RB, Kjeldsen SE, et al. LIFE Study Group: cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003. (Pubitemid 34286536)
24. Shen L, Shah BR, Reyes EM, et al. Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study. BMJ 2013;347:f6745.
25. Zillich AJ, Garg J, Basu S, et al. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006;48:219-24. (Pubitemid 44309815)
26. Gurwitz JH, Kalish SC, Bohn RL, et al. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol 1997;50:953-9. (Pubitemid 27423526)